Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

302

HTML

2802

Tables (1-3)

183

Sum=3287

Nov 27, 2011 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Nov 27, 2011; 3(11): 278-284
Published online Nov 27, 2011. doi: 10.4254/wjh.v3.i11.278

Table 3 Results of antiviral treatment in patients with low grade B cell-non Hodgkin’s lymphoma

	Sex	Age (yr)	Histology	Stage	HCVRNA log₁₀ (UI/mL)	Genotype	Staging (Ishak)	Treatment	Treatment duration (mo)	Response to treatment	Remission lymphoma
1	F	70	Marginal extranodal	IV	5.9	2a/2c	0	Peg 180 μg/wk + RBV 800 mg/d	6	SVR	Complete hematological response
2	F	69	Marginal extranodal	IV	5.4	2a	6	Peg 180 μg/wk + RBV 800 mg/d	6	SVR	Complete hematological response
3	F	64	Marginal extranodal	IV	5.6	1b	nd	Peg 180 μg/wk + RBV 1000 mg/d	12	Relapser	Progressive disease
4	M	36	Marginal splenic	IV	5.5	2	1	Peg 180 μg/wk + RBV 800 mg/d	6	SVR	Partial response
5	F	72	Marginal splenic	III	6.0	1b	2	Peg 180 μg/wk + RBV 1000 mg/d	12	SVR	Partial response
6	F	65	Marginal splenic	IV	5.6	2a/2c	nd	Peg 180 μg/wk + RBV 1200 mg/d	6	SVR	Complete hematological response
7	F	70	Marginal nodal	IV	5.9	2	2	Peg 180 μg/wk + RBV 800 mg/d	6	SVR	Complete hematological response
8	F	55	Follicular lymphoma	III	5.0	2a/2c	6	Peg 180 μg/wk + RBV 800 mg/d	6	Relapser	Progressive disease
9	M	67	Follicular lymphoma	IV	6.8	2a	0	Peg 180 μg/wk + RBV 800 mg/d	6	SVR	Complete hematological response

MU: Million of units; RBV: Ribavirin; SVR: Sustained virological response.

Citation: Pellicelli AM, Marignani M, Zoli V, Romano M, Morrone A, Nosotti L, Barbaro G, Picardi A, Gentilucci UV, Remotti D, D'Ambrosio C, Furlan C, Mecenate F, Mazzoni E, Majolino I, Villani R, Andreoli A, Barbarini G. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World J Hepatol 2011; 3(11): 278-284
URL: https://www.wjgnet.com/1948-5182/full/v3/i11/278.htm
DOI: https://dx.doi.org/10.4254/wjh.v3.i11.278